个人简历
1、生物大分子定向改造与成药性评价
研究方向
1、生物大分子定向改造与成药性评价
主持在研项目情况
无
近年代表性科研成果
1. Pei Du; Ting Wang; Hang Wang; Meijia Yang; Hongping Yin ; Mucin‐fused myeloid‐derivedgrowth factor (MYDGF164) exhibits a prolonged serum half‐life and alleviates fibrosis in chronic kidney disease, British Journal of Pharmacology, 2022, 179(16): 4136-4156
2. Du, Pei; Wang, Xiaonan; Yin, Tianqi; Zhang, Xueqing; Zhang, Zhiyuan; Yu, Weihong; Wang,Min; Luo, Chen; Yu, Luting ; Anti-tumor effect of single-chain antibody to Reg3a in colorectalcancer, EXPERIMENTAL CELL RESEARCH, 2020, 396(1)
